Literature DB >> 15203416

Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users.

A Loughlin1, L Metsch, L Gardner, P Anderson-Mahoney, M Barrigan, S Strathdee.   

Abstract

We aimed to identify factors associated with a medical provider's resistance to prescribing HAART to medically-eligible HIV-infected illicit drug users. In four US cities, a mailed, self-administered survey queried 420 HIV care providers about patients' characteristics and barriers to care. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated using logistic regression. Providers identified as resistant to prescribing HAART to medically-eligible HIV-infected illicit drug users were more likely to be non-physicians (AOR=1.89, 95% CI: 1.04-3.46), to work in populations with a high prevalence of both mental illness (AOR=2.42; 95% CI: 1.11-5.26) and injection drug use (AOR=1.82 95% CI: 1.02-3.25) and were deterred from prescribing HAART by patients' limited ability to keep appointments, (AOR=3.19; 95% CI: 1.39-7.37), alcoholism (AOR=1.92; 95% CI: 1.04-3.55) and homelessness (AOR=1.81; 95% CI: 1.07-3.06). Providers working in populations with a high injection drug use prevalence commonly reported higher prevalence of non-injection drug use, alcohol problems and mental illness, and higher antiretroviral therapy refusal rates within their patient populations. Our findings underscore the challenges to providers who treat HIV-infected drug users and suggest that their care and treatment would benefit from on-site drug treatment, mental health and social services.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  2004        PMID: 15203416     DOI: 10.1080/09540120410001683411

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  24 in total

1.  Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users.

Authors:  Scott E Hadland; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; Robert S Hogg; Julio S Montaner; Evan Wood
Journal:  AIDS Patient Care STDS       Date:  2012-03-19       Impact factor: 5.078

2.  Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems.

Authors:  John Orwat; Richard Saitz; Christopher P Tompkins; Debbie M Cheng; Michael P Dentato; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2011-06-22

3.  Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users.

Authors:  Thomas Kerr; Brandon D L Marshall; M-J Milloy; Ruth Zhang; Silvia Guillemi; Julio S G Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2012-01-14       Impact factor: 4.492

4.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

5.  HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Authors:  Frederick L Altice; R Douglas Bruce; Gregory M Lucas; Paula J Lum; P Todd Korthuis; Timothy P Flanigan; Chinazo O Cunningham; Lynn E Sullivan; Pamela Vergara-Rodriguez; David A Fiellin; Adan Cajina; Michael Botsko; Vijay Nandi; Marc N Gourevitch; Ruth Finkelstein
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

6.  Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States.

Authors:  Alison J Hughes; Christine L Mattson; Susan Scheer; Linda Beer; Jacek Skarbinski
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

7.  Drinking motives as prospective predictors of outcome in an intervention trial with heavily drinking HIV patients.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Milton Wainberg; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2013-11-05       Impact factor: 4.492

8.  Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest Uganda.

Authors:  Priscilla Martinez; Irene Andia; Nneka Emenyonu; Judith A Hahn; Edvard Hauff; Larry Pepper; David R Bangsberg
Journal:  AIDS Behav       Date:  2007-10-30

9.  "It's Never Just About the HIV:" HIV Primary Care Providers' Perception of Substance Use in the Era of "Universal" Antiretroviral Medication Treatment.

Authors:  Aimee N C Campbell; Margaret Wolff; Laurel Weaver; Don Des Jarlais; Susan Tross
Journal:  AIDS Behav       Date:  2018-03

10.  Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services.

Authors:  Laurie Sylla; R Douglas Bruce; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2007-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.